WD-870

N/A

Report date: 2024/02/06 15:03:37

Base Information

Drug NameWD-870
Drug Alias NameWD-870
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitors
TargetsBromodomain and extra terminal domain protein
Therapy Area/IndicationsNUT midline carcinomaLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNingbo Wenda Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNingbo Wenda Pharma
Inactive CompaniesN/A
Active IndicationsNUT midline carcinomaLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A